NOVA2 Antikörper (Middle Region)
Kurzübersicht für NOVA2 Antikörper (Middle Region) (ABIN629943)
Target
Alle NOVA2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- Middle Region
-
Spezifität
- NOVA2 antibody was raised against the middle region of NOVA2
-
Aufreinigung
- Purified
-
Immunogen
- NOVA2 antibody was raised using the middle region of NOVA2 corresponding to a region with amino acids EPEQVHKAVSAIVQKVQEDPQSSSCLNISYANVAGPVANSNPTGSPYASP
-
-
-
-
Applikationshinweise
-
WB: 2.5 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
NOVA2 Blocking Peptide, catalog no. 33R-2631, is also available for use as a blocking control in assays to test for specificity of this NOVA2 antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of NOVA2 antibody in PBS
-
Konzentration
- Lot specific
-
Buffer
- PBS
-
Handhabung
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- NOVA2 (Neuro-Oncological Ventral Antigen 2 (NOVA2))
-
Andere Bezeichnung
- NOVA2
-
Hintergrund
- NOVA2 may regulate RNA splicing or metabolism in a specific subset of developing neurons. It binds single strand RNA.
-
Molekulargewicht
- 54 kDa (MW of target protein)
Target
-